Latest DEF 14A proxy statements
NASDAQ
Astrana Health, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and a proposal to increase equity incentive plan shares.
NYSE
Stellus Capital Investment Corporation is seeking shareholder approval for a new investment advisory agreement following the acquisition of its advisor by Ridgepost Capital.
NYSE
Dream Finders Homes announces its 2026 Annual Meeting, proposing a reincorporation to Texas and conversion of Series A Preferred Stock.
NASDAQ
NTGR
Netgear, INCNETGEAR, Inc. has released its 2026 proxy statement detailing director elections, executive compensation, and corporate governance updates.
NASDAQ
NFLX
Netflix INCNetflix reports strong 2025 financial performance and announces the upcoming departure of co-founder Reed Hastings from the Board.
NYSE
SEACOR Marine Holdings Inc. has issued its 2026 proxy statement detailing director elections, executive compensation, and auditor ratification.
NASDAQ
FRP Holdings, Inc. has issued its 2026 proxy statement to solicit shareholder votes for director elections, a new equity incentive plan, and advisory executive compensation.
NASDAQ
Rani Therapeutics Holdings, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on May 28, 2026.
NYSE
Salesforce outlines its strategic pivot to the 'Agentic Revolution' and details executive compensation tied to AI product adoption.
OQX
TSNDF
Terrascend CORPTerrAscend Corp. has issued its proxy statement for the 2026 Annual Meeting of Shareholders to be held virtually on June 9, 2026.
NASDAQ
Meta Platforms, Inc. releases its 2026 proxy statement detailing board nominations, executive compensation, and responses to twelve shareholder proposals.
NASDAQ
Kiniksa Pharmaceuticals International, plc has scheduled its 2026 Annual Meeting of Shareholders for May 29, 2026, to address director re-elections, auditor appointments, and executive compensation.
NYSE
VAL
Valaris LTDValaris Limited filed its 2026 proxy statement detailing director elections and the pending business combination with Transocean.
NYSE
Tenet Healthcare reports strong 2025 financial performance, including a 21.4% adjusted EBITDA margin and significant capital deployment, ahead of its 2026 Annual Meeting.
NASDAQ
Axon Enterprise reports record 2025 revenue of $2.8 billion and outlines its AI-driven growth strategy in its 2026 proxy statement.
NYSE
Arbor Realty Trust has filed its 2026 proxy statement, outlining proposals for director elections, an increase in stock incentive plan shares, and executive compensation advisory votes.
NYSE
Excelerate Energy, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation disclosures.
NASDAQ
DOCU
Docusign, INCDocuSign's 2026 proxy statement outlines board refreshment, executive compensation adjustments, and upcoming governance changes.
NYSE
Third Coast Bancshares, Inc. has issued its 2026 proxy statement detailing director elections, executive compensation plan amendments, and auditor ratification.
NYSE
Four Corners Property Trust, Inc. has scheduled its 2026 Annual Meeting of Stockholders for June 4, 2026, to address director elections, auditor ratification, and executive compensation.
NASDAQ
NGNE
Neurogene INCNeurogene Inc. has issued its 2026 proxy statement detailing the agenda for its upcoming virtual annual meeting of stockholders on June 3, 2026.
OQB
Pharma-Bio Serv, Inc. has issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders scheduled for May 15, 2026.
NYSE
Colony Bankcorp, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation advisory votes.
NASDAQ
Impinj, Inc. has filed its 2026 proxy statement detailing director elections, executive compensation, and a new 2026 Equity Incentive Plan.
NASDAQ
Esperion Therapeutics announces its 2026 Annual Meeting of Stockholders to be held virtually on May 28, 2026, featuring key proposals including a 7,000,000 share increase to its 2022 Stock Option and Incentive Plan.
NASDAQ
Vince Holding Corp. has issued its 2026 proxy statement detailing director elections, executive compensation, and a proposed increase in equity incentive plan shares.
AMEX
Perspective Therapeutics, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting agenda, including director elections and executive compensation votes.
NASDAQ
First Interstate BancSystem, Inc. announces its 2026 Annual Meeting of Shareholders to be held on May 27, 2026.
NYSE
ACVA
Acv Auctions INCACV Auctions Inc. announces its 2026 Annual Meeting of Shareholders to be held virtually on May 27, 2026.
NASDAQ
GOGO
Gogo INCGogo Inc. has issued its 2026 proxy statement, seeking stockholder approval for director elections, executive compensation, and an amended equity incentive plan.